Carla Treloar

Director and Scientia Professor
Director

Professor Carla Treloar is Director of the Centre for Social Research in Health and the Social Policy Research Centre.

Carla's research interests are in the fields of hepatitis C and injecting drug use. She is a primarily qualitative researcher and is grounded in the disciplines of health and social psychology, public health and health policy. However, Carla constantly seeks to work across methods and disciplines. In particular, she sees it essential to work towards blending the insights that an individual-based discipline like health psychology can provide when issues such as hepatitis C and illicit drug use are considered in social, legal and political contexts.

Carla is member of many advisory groups for research, government and non-government agencies. A few keyappointments are listed below.

Publications

Book Chapters
add
Madden A; Lennon P; Hogan C; Getty M; Hopwood M; Neale J; Treloar C, 2019, 'Patient-reported measures as a justice project through involvement of service-user researchers', in Practical Justice: Principles, Practice and Social Change, pp. 190 - 199
2019
Treloar C, 2014, 'Applying Principles of Mindlessness-Mindfulness Theory and Drug-Injecting Behavior', in The Wiley Blackwell Handbook of Mindfulness, pp. 818 - 833, http://dx.doi.org/10.1002/9781118294895.ch41
2014
Conference Abstracts
add
Valerio H; Alavi M; Silk D; Treloar C; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Degenhardt L; Dore G; Grebely J, 2019, 'Uptake of testing, linkage to care, and treatment for hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage study', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, Vol. 70, pp. E42 - E42, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1016/S0618-8278(19)30076-3
2019
Grebely J; Marshall AD; Krahe M; Erratt A; Telenta J; Treloar C; Jones SC; Adey S; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop AJ; Applegate TL; Lamoury F; Mowat Y; Jauncey M; Read P; Gilliver R; Smith J; Collie T; Dore GJ, 2016, 'A LIVER HEALTH PROMOTION INTERVENTION INTEGRATING NON-INVASIVE LIVER DISEASE SCREENING IN DRUG AND ALCOHOL SETTINGS: THE LIVERLIFE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 40 - 40, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2016
Alavi M; Grebely J; Micallef M; Dunlop A; Balcomb A; Day C; Treloar C; Bath N; Haber P; Dore G, 2015, 'TREATMENT FOR HEPATITIS C VIRUS INFECTION AMONG PEOPLE WHO INJECT DRUGS IN THE OPIOID SUBSTITUTION SETTING: THE ETHOS STUDY', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Vienna, AUSTRIA, Vol. 62, pp. S673 - S673, presented at 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, AUSTRIA, 22 April 2015 - 26 April 2015, http://dx.doi.org/10.1016/S0168-8278(15)31085-0
2015
Conference Papers
add
Gray RM; Kelly PJ; Beck AK; Baker AL; Deane FP; Neale J; Treloar C; Hides L; Manning V; Shakeshaft A; Kelly J; Argent A; McGlaughlin R, 2020, 'A qualitative exploration of SMART Recovery meetings in Australia and the role of a digital platform to support routine outcome monitoring', in Addictive Behaviors, http://dx.doi.org/10.1016/j.addbeh.2019.106144
2020
Hajarizadeh B; Marshall AD; Grebely J; Dore GJ; Treloar C; Corry A; Hayllar J; Byrne J, 2019, 'SYMPOSIUM: ENHANCING HEPATITIS C CARE AMONG PEOPLE WHO INJECT DRUGS', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S8 - S9, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Rance J; Lafferty L; Treloar C, 2019, 'PROMISE AND PHARMACEUTICALISATION IN THE ERA OF DIRECT-ACTING ANTIVIRALS', Montreal, Cananda, presented at International Symposium on Hepatitis Care in Substance Users, Montreal, Cananda, 11 September 2019 - 13 September 2019
2019
Reilly R; Gendera S; Treloar C; Azzopardi P; Svensson F; Fisher I; Longbottom W; Ward J, 2019, 'IDENTIFYING RISK AND PROTECTIVE FACTORS FOR METHAMPHETAMINE USE IN ABORIGINAL COMMUNITIES: RELEVANCE OF THE 'COMMUNITIES THAT CARE' MODEL', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S86 - S86, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Reilly R; Wand H; McKetin R; Ezard N; Dunlop AJ; Conigrave KM; Quinn B; Gray D; Wilkes E; Treloar C; Fisher I; Longbottom W; Ward J, 2019, 'METHODS OF DATA COLLECTION AND CHARACTERISTICS OF A SAMPLE OF METHAMPHETAMINE USERS: FINDINGS FROM THE NOVEL INTERVENTIONS TO ADDRESS METHAMPHETAMINE USE IN ABORIGINAL AND TORRES STRAIT ISLANDER COMMUNITIES SURVEY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S86 - S87, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2019
Valerio H; Alavi M; Silk D; Treloar C; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Degenhardt L; Dore G; Grebely J, 2019, 'Uptake of testing, linkage to care, and treatment for hepatitis C infection among people who inject drugs in Australia: The ETHOS Engage study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Vienna, AUSTRIA, pp. E42 - E42, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 - 14 April 2019,
2019
Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin N; Mchutchison JG; Brainard D; Treloar C; Lloyd A; Dore G, 2018, 'Incidence of hepatitis C virus infection in four prisons in New South Wales, Australia: The SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Paris, FRANCE, pp. S187 - S188, presented at International Liver Congress (ILC), Paris, FRANCE, 11 - 15 April 2018,
2018
Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin N; Mchutchison JG; Brainard D; Treloar C; Lloyd A; Dore G, 2018, 'Incidence of hepatitis C virus infection in four prisons in New South Wales, Australia: The SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Paris, FRANCE, pp. S187 - S188, presented at International Liver Congress (ILC), Paris, FRANCE, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30587-7
2018
Lord HL; Newland J; Cama E; Treloar C; Levy MT, 2014, 'Understanding the Phases of Chronic Hepatitis B; the problem and a novel solution using renamed phases, the Hepatitis B Bear and a video (see " Understanding Hepatitis B " on YouTube)', in HEPATOLOGY, WILEY-BLACKWELL, Boston, MA, pp. 1001A - 1002A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 07 November 2014 - 11 November 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483804231&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2014
Lord H; Treloar C; Cama E; Newland J; Levy MT, 2014, 'Understanding the phases of chronic hepatitis B: the problem and a novel solution using renamed phases, the hepatitis B bear and a video (see "Understanding Hepatitis B" on YouTube)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 86 - 86, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2014
Treloar C, 2013, '"YOU'VE GOT CONTROL OF THE PUMP": THE IMPORTANCE OF TRUST IN THE DRUG TREATMENT CLINIC', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 3 - 4, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2013
Treloar C; Fraser S, 2008, 'Hepatitis C treatment in pharmacotherapy services: increasing treatment uptake needs a critical view', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A338 - A339, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2008
Conference Posters
add
Lafferty LM; Rance J; Treloar C, 2017, 'Treatment as prevention in the prison setting: Prisoners’ perspectives', presented at Australasian Viral Hepatitis Elimination Conference, 10 August 2017 - 11 August 2017
2017
Lafferty LM; Rance J; Treloar C, 2017, 'Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia’s current policy frameworks.', Cairns, Queensland, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, Queensland, 10 August 2017 - 11 August 2017
2017
Lafferty LM; Rance J; Treloar C, 2017, 'Does Australia’s policy landscape support HCV treatment as prevention in the prison setting in the new DAA era?', New Jersey, USA, presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017
2017
Rance JA; Treloar C; Rhodes T; Bryant J; Fraser S, 2015, '"It’s not only my life I got to worry about"’: accounts of needle-syringe sharing and negotiated safety among couples who inject drugs.', Manly, Sydney, presented at 4th International Symposium on Hepatitis Care in Substance Use, Manly, Sydney, 07 October 2015 - 09 October 2015
2015
Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Sydney, Australia, presented at 4th International Symposium on Hepatitis Care in Substance Users, Sydney, Australia, 07 October 2015 - 09 October 2015
2015
Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Hawaii, USA, presented at HEP DART 2015, Hawaii, USA, 06 December 2015 - 10 December 2015
2015
Rance JA; Lafferty L; Treloar C, '“Behind closed doors, no one sees, no one knows”: Stigma and treatment as prevention in prison', Cairns, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, 10 August 2017 - 11 August 2017
Conference Presentations
add
Rance J; Lafferty L; Treloar C, 2018, 'The Matter of Reinfection: Attitudes among Australian Prisoners from the SToP-C Study', presented at Australasian Viral Hepatitis Conference 2018, Adelaide, 13 August 2018 - 15 August 2018
2018
Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin NK; Mchutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore GJ, 2017, 'Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the SToP-C study', Vol. 66, pp. S274 - S274, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30862-0
2017
Byrne M; Hajarizadeh B; Dore GJ; Treloar C; Marks P; Milat A; Bowman J; McGrath C; Bath N; Calder I; Lagios K; Grebely J; Lloyd A, 2017, 'A framework for hepatitis C virus treatment as prevention in the prison setting: the SToP-C implementation toolkit', Vol. 66, pp. S495 - S495, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31387-9
2017
Lafferty LM; Rance J; Treloar C, 2017, 'Prisoners' perspectives of treatment as prevention for hepatitis C in the prison setting', presented at HEP DART, Hawaii, USA, 03 December 2017 - 07 December 2017
2017
Lafferty LM; Rance J; Treloar C, 2017, 'Treatment as Prevention in the Prison Setting: Prisoners' Perspectives', presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017
2017
Wadolowski M; Guy R; Ford B; Hengel B; Treloar C; Newman CE; Tapia M; Cairnduff S; Duck T; Tawil V; Pritchard-Jones J; Dulwarie N; Donovan S; Kong M, 2016, 'Improving STI/BBV testing and management in Aboriginal community controlled health services: A systematic review of what works, what doesn’t', presented at 2017 Australasian HIV & AIDS Conference, Adelaide, 14 November 2016 - 16 November 2016
2016
Hajarizadeh B; Grebely J; Byrne M; Marks P; Butler T; Amin J; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore G, 2016, 'Hepatitis C virus exposure, infection and associated risk behaviours in two maximum-security prisons in New South Wales, Australia', Vol. 64, pp. 385A - 386A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Boston, MA, 11 November 2016 - 15 November 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493802052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2016
Lafferty LM; Treloar C; Chambers GM; Butler T; Guthrie J, 2016, 'Exploring dimensions of social capital of men in prison living with hepatitis C', presented at Social Research Conference on HIV, Viral Hepatitis and Related Diseases, 31 March 2016 - 01 April 2016
2016
Lafferty LM; Treloar C; Butler T, 2016, 'Building social capital to promote HCV treatment in prison', presented at National Hepatitis Health Promotion Conference, Melbourne, Australia, 19 May 2016 - 20 May 2016
2016
Lafferty LM; Treloar C; Guthrie J; Chambers GM; Butler T, 2016, 'Utilising social capital to promote HCV treatment in prison', presented at 5th International Symposium on Hepatitis Care in Substance Users (INHSU), Oslo, Norway, 07 September 2016 - 09 September 2016
2016
Lafferty LM; Treloar C; Guthrie J; Chambers GM; Butler T, 2016, 'Relationships Matter: Social capital theory and the delivery of hepatitis C treatment in prison', presented at 10th Australasian Viral Hepatitis Conference, Gold Coast, Australia, 29 September 2016 - 01 October 2016
2016
Rance J; Treloar C, 2016, ''I’m always going to be with you, so don’t worry': Accounts of changing hepatitis C serostatus among couples who inject drugs', presented at 14th Social Research Conference on HIV, Viral Hepatitis and Related Diseases, Sydney, 31 March 2016 - 01 April 2016
2016
Lafferty LM; Treloar C; Steele M; van Breda N; Hiley S; Salmon A, 2016, 'Preparing Prescription Opiates for Injection: Understanding Preferences and Practices', presented at Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Sydney, Australia, 30 October 2016 - 02 November 2016
2016
Rance JA; Treloar C; Rhodes T; Bryant J; Fraser S, 2015, '‘It’s not only my life I got to worry about’: Accounts of needle-syringe sharing and negotiated safety among couples who inject drugs.', presented at 4th International Symposium on Hepatitis Care in Substance Use, Manly, Sydney, 07 October 2015 - 09 October 2015
2015
Treloar C, 2014, '“You’ve Got Control Of The Pump”: The Importance Of Trust In The Drug Treatment Clinic. [invited plenary]', presented at Alcohol, Tobacco and Other Drugs Council (ATDC) Conference, Hobart, 07 May 2014 - 08 May 2014
2014
Treloar C, 2014, '“You’ve Got Control Of The Pump”: The Importance Of Trust In The Drug Treatment Clinic. [invited plenary]', presented at Network of Alcohol and Drug Agencies (NADA) Conference, Sydney, 12 May 2014 - 13 May 2014
2014
Treloar C, 2014, 'Social Issues in HCV. [invited plenary]', presented at 3rd Canadian Symposium on HCV, Toronto, Canada, 07 February 2014 - 07 February 2014
2014
Rance JA; Treloar C, 2014, '“A Place To Say Something”: Drug treatment, the ‘therapeutic alliance’ & the possibilities of consumer participation.', presented at 13th Social Research Conference on HIV, viral hepatitis and related diseases, Sydney, 20 February 2014 - 21 February 2014
2014
Rance JA; Fraser S; Bryant J; Treloar C, 2014, 'Negotiating risk, navigating relationship: accounts of needle-syringe sharing within romantic partnerships.', presented at 9th Australasian Viral Hepatitis Conference, Alice Springs, 17 September 2014 - 19 September 2014
2014
Treloar C, 2013, '“You’ve Got Control Of The Pump”: The Importance Of Trust In The Drug Treatment Clinic. [invited plenary]', presented at Australasian Professional Society on Alcohol & other Drugs (APSAD), Brisbane, 25 November 2013 - 27 November 2013
2013
Treloar C, 2013, 'Barriers to hepatitis C assessment and care: Navigating the patient-, provider- and systems-levels. [invited presentation]', presented at 3rd International Symposium on Hepatitis Care in Substance Users, Munich, Germany, 05 September 2013 - 06 September 2013
2013
Rance JA; Treloar C, 2012, 'There’s only win-win-win’: stories of hepatitis C treatment and transformative possibility from opiate substitution clinics', presented at 12th Social Research Conference on HIV, Hepatitis C and Related Diseases, Sydney, 12 April 2012 - 13 April 2012
2012
Rance JA; Treloar C, 2012, '"There’s only win-win-win": stories of hepatitis C treatment and transformative possibility from opiate substitution clinics.', presented at 12th Social Research Conference on HIV, Hepatitis C and Related Diseases, Sydney, 12 April 2012 - 13 April 2012
2012
Rance JA; Treloar C, 2012, 'Providing hepatitis C care and treatment in opiate substitution settings: A qualitative evaluation of four ETHOS sites', presented at 8th Australasian Viral Hepatitis Conference, Auckland, 10 September 2012 - 12 September 2012
2012
Rance JA; Treloar C, 2011, 'Negotiating Care: Opiate substitution, hepatitis C treatment and the ‘risky’ client', presented at 16th Australian Sociological Society Conference, Newcastle, 29 November 2011 - 01 December 2011
2011
Treloar C; Holt M, 2005, 'Service providers’ perspectives on barriers to illicit drug treatment', presented at 16th International Conference on the Reduction of Drug Related Harm, Belfast, 20 March 2005 - 24 March 2005
2005
Lafferty L; Rance J; Treloar C, 'Injecting culture following prison-wide hepatitis c treatment scale-up: negotiating risk after cure', presented at Australasian Viral Hepatitis Elimination Conference, Sydney, Australia, 05 August 2019 - 06 August 2019
Rance J; Lafferty L; Treloar C, 'Reinfection and retreatment: Attitudes among prisoner participants from the Australian SToP-C study', presented at 7th International Symposium on Hepatitis Care in Substance Users, Cascais, Portugal, 19 September 2018 - 21 September 2018
Journal articles
add
Day E; Hellard M; Treloar C; Bruneau J; Martin NK; Øvrehus A; Dalgard O; Lloyd A; Dillon J; Hickman M; Byrne J; Litwin A; Maticic M; Bruggmann P; Midgard H; Norton B; Trooskin S; Lazarus JV; Grebely J, 2019, 'Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework', Liver International, vol. 39, pp. 20 - 30, http://dx.doi.org/10.1111/liv.13949
2019
Miller K; Sheaves F; Maher L; Page J; Bridges-Webb I; Treloar C, 2019, '‘C’ the potential: needle and syringe programs as hepatitis C treatment sites', Drugs: Education, Prevention and Policy,
2019
Walker M; Beadman K; Griffin S; Beadman M; Treloar C, 2019, 'Involving peers in research: The UNSW community reference panel', Harm Reduction Journal, vol. 16, pp. 52, http://dx.doi.org/10.1186/s12954-019-0325-3
2019
Reilly R; McKetin R; Wand H; Butt J; Smout M; Ezard N; Conigrave K; Clark Y; Quinn B; Treloar C; Gray D; Dunlop A; Roe Y; Ward J, 2019, 'A web-based therapeutic program (We Can Do This) for reducing methamphetamine use and increasing help-seeking among aboriginal and torres strait islander people: Protocol for a randomized wait-list controlled trial', Journal of Medical Internet Research, vol. 21, http://dx.doi.org/10.2196/14084
2019
Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT; Dunlop A; Zekry A; Lloyd A; Duvnjak A; Treloar C; Tyrrell H; George J; Iversen J; Marriott K; Crooks L; Maher L; Douglas M, 2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, vol. 26, pp. 83 - 92,
2019
Kwon JA; Dore GJ; Grebely J; Hajarizadeh B; Guy R; Cunningham EB; Power C; Estes C; Razavi H; Gray RT; Dunlop A; Zekry A; Lloyd A; Duvnjak A; Treloar C; Tyrrell H; George J; Iversen J; Marriott K; Crooks L; Maher L; Douglas M, 2019, 'Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study', Journal of Viral Hepatitis, vol. 26, pp. 83 - 92, http://dx.doi.org/10.1111/jvh.13013
2019
Marshall AD; Madden A; Treloar C, 2019, 'Enhancing engagement in hepatitis C care among people who inject drugs', Addiction,
2019
Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J, 2019, 'Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs', International Journal of Drug Policy, vol. 66, pp. 87 - 93, http://dx.doi.org/10.1016/j.drugpo.2019.01.012
2019
Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J, 2019, 'Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs', International Journal of Drug Policy, vol. 66, pp. 87 - 93,
2019
Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C, 2019, 'Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all', International Journal of Drug Policy, vol. 72, pp. 1 - 10, http://dx.doi.org/10.1016/j.drugpo.2019.07.016
2019
Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ, 2019, 'Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study', Journal of Viral Hepatitis, vol. 26, pp. 969 - 979, http://dx.doi.org/10.1111/jvh.13112
2019
Marshall AD; Madden A; Treloar C, 2019, 'Enhancing engagement in hepatitis C care among people who inject drugs', Addiction, http://dx.doi.org/10.1111/add.14698
2019
Lafferty L; Rance J; Treloar C, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, vol. 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135
2019
Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ, 2019, 'Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness', Journal of Viral Hepatitis,
2019
Miller K; Sheaves F; Maher L; Page J; Bridges-Webb I; Treloar C, 2019, '‘C’ the potential: needle and syringe programs as hepatitis C treatment sites', Drugs: Education, Prevention and Policy, http://dx.doi.org/10.1080/09687637.2019.1583170
2019
Marshall AD; Grebely J; Dore GJ; Treloar C, 2019, 'Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists-The practitioner experience.', Drug Alcohol Depend, pp. 107705, http://dx.doi.org/10.1016/j.drugalcdep.2019.107705
2019
Levy MH; Treloar CJ, 2018, 'Health protection and australian prisons, 2018', Medical Journal of Australia, vol. 209,
2018
Lafferty L; Wild TC; Rance J; Treloar C, 2018, 'A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons', Harm Reduction Journal, vol. 15, http://dx.doi.org/10.1186/s12954-018-0246-6
2018
Lafferty L; Rance J; Treloar C, 2018, 'Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting', Drug and Alcohol Dependence, vol. 183, pp. 96 - 101, http://dx.doi.org/10.1016/j.drugalcdep.2017.10.030
2018
Levy M; Treloar C, 2018, 'Health protection and Australian prisons, 2018', The Medical Journal of Australia, vol. 209, pp. 460 - 461, http://dx.doi.org/10.5694/mja18.00669
2018
Rance J; Lafferty L; Treloar C, 2018, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, http://dx.doi.org/10.1080/09581596.2018.1541225
2018
Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J, 2018, 'Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia', International Journal of Drug Policy, vol. 61, pp. 23 - 30, http://dx.doi.org/10.1016/j.drugpo.2018.08.011
2018
Rance J; Rhodes T; Fraser S; Bryant J; Treloar C, 2018, 'Practices of partnership: Negotiated safety among couples who inject drugs', Health (United Kingdom), vol. 22, pp. 3 - 19,
2018
Madden A; Hopwood M; Neale J; Treloar C, 2018, 'Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?', PLoS ONE, vol. 13,
2018
Lafferty L; Chambers GM; Guthrie J; Butler T; Treloar C, 2018, 'Measuring Social Capital in the Prison Setting: Lessons Learned From the Inmate Social Capital Questionnaire', Journal of Correctional Health Care, vol. 24, pp. 407 - 417, http://dx.doi.org/10.1177/1078345818793141
2018
Lafferty L; Rance J; Grebely J; Lloyd AR; Dore GJ; Treloar C, 2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, vol. 25, pp. 1526 - 1532, http://dx.doi.org/10.1111/jvh.12987
2018
Hickman M; Grebely J; Bruneau J; Coffin P; Degenhardt L; Hutchinson S; Larney S; Martin N; Treloar C; Vickerman P, 2017, 'New developments and opportunities for preventing hepatitis C virus (HCV) among people who use and inject drugs—announcing an Addiction series', Addiction, vol. 112, pp. 1126 - 1127, http://dx.doi.org/10.1111/add.13847
2017
Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J; Haber P; Rawlinson W; Treloar C; Maher L, 2017, 'Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study', Journal of Viral Hepatitis, vol. 24, pp. 733 - 741, http://dx.doi.org/10.1111/jvh.12701
2017
Fortier E; Alavi M; Bruneau J; Micallef M; Perram J; Sockalingam S; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ; Grebely J, 2017, 'Depression, Anxiety, and Stress among People with Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia', Journal of Addiction Medicine, vol. 11, pp. 10 - 18, http://dx.doi.org/10.1097/ADM.0000000000000261
2017
Lafferty L; Treloar C; Guthrie J; Chambers GM; Butler T, 2017, 'Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison', Journal of Viral Hepatitis, vol. 24, pp. 111 - 116, http://dx.doi.org/10.1111/jvh.12627
2017
Newman CE; Gray R; Brener L; Jackson LC; Dillon A; Saunders V; Johnson P; Treloar C, 2017, '"i had a little bit of a bloke meltdown...But the next day, i was up": Understanding cancer experiences among aboriginal men', Cancer Nursing, vol. 40, pp. E1 - E8,
2017
Grebely J; Bruneau J; Bruggmann P; Harris M; Hickman M; Rhodes T; Treloar C, 2017, 'Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy', International Journal of Drug Policy, vol. 47, pp. 26 - 33, http://dx.doi.org/10.1016/j.drugpo.2017.08.001
2017
Marshall AD; Grebely J; Dore GJ; Treloar C, 2017, '‘I didn't want to let it go too far.’ The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife study', International Journal of Drug Policy, vol. 47, pp. 153 - 160, http://dx.doi.org/10.1016/j.drugpo.2017.06.001
2017
Grebely J; Bruneau J; Lazarus JV; Dalgard O; Bruggmann P; Treloar C; Hickman M; Hellard M; Roberts T; Crooks L; Midgard H; Larney S; Degenhardt L; Alho H; Byrne J; Dillon JF; Feld JJ; Foster G; Goldberg D; Lloyd AR; Reimer J; Robaeys G; Torrens M; Wright N; Maremmani I; Norton BL; Litwin AH; Dore GJ, 2017, 'Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs', International Journal of Drug Policy, vol. 47, pp. 51 - 60, http://dx.doi.org/10.1016/j.drugpo.2017.05.019
2017
Lafferty L; Treloar C; van Breda N; Steele M; Hiley S; Flaherty I; Salmon A, 2017, '‘It's Fast, It's Quick, It Stops Me Being Sick’: How to influence preparation of opioid tablets for injection', Drug and Alcohol Review, vol. 36, pp. 651 - 657, http://dx.doi.org/10.1111/dar.12562
2017
Marshall AD; Saeed S; Barrett L; Cooper CL; Treloar C; Bruneau J; Feld JJ; Gallagher L; Klein MB; Krajden M; Shoukry NH; Taylor LE; Grebely J; Canadian Network on Hepatitis C (CanHepC) , 2016, 'Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study.', CMAJ Open, vol. 4, pp. E605 - E614, http://dx.doi.org/10.9778/cmajo.20160008
2016
Treloar C; McCredie L; Lloyd AR, 2016, 'The prison economy of needles and syringes: What opportunities exist for blood borne virus risk reduction when prices are so high?', PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0162399
2016
Treloar C; Jackson C; Gray R; Newland J; Wilson H; Saunders V; Johnson P; Brener L, 2016, 'Care and treatment of hepatitis C among Aboriginal people in New South Wales, Australia: Implications for the implementation of new treatments', Ethnicity and Health, vol. 21, pp. 39 - 57,
2016
Lafferty L; Treloar C; Chambers GM; Butler T; Guthrie J, 2016, 'Contextualising the social capital of Australian Aboriginal and non-Aboriginal men in prison', Social Science and Medicine, vol. 167, pp. 29 - 36, http://dx.doi.org/10.1016/j.socscimed.2016.08.040
2016
Lafferty L; Treloar C; Butler T; Guthrie J; Chambers GM, 2016, 'Unlocking dimensions of social capital in the prison setting', Health and Justice, vol. 4, http://dx.doi.org/10.1186/s40352-016-0040-z
2016
Grebely J; Alavi M; Micallef M; Dunlop AJ; Balcomb AC; Phung N; Weltman MD; Day CA; Treloar C; Bath N; Haber PS; Dore GJ, 2016, 'Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: The ETHOS Study', Addiction, vol. 111, pp. 311 - 319,
2016
Grebely J; Alavi M; Micallef M; Dunlop AJ; Balcomb AC; Phung N; Weltman MD; Day CA; Treloar C; Bath N; Haber PS; Dore GJ, 2016, 'Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: The ETHOS Study', Addiction, vol. 111, pp. 311 - 319, http://dx.doi.org/10.1111/add.13197
2016
Newland ; Newman C; Treloar C, 2016, '“We get by with a little help from our friends”: Small-scale informal and large-scale formal peer distribution networks of sterile injecting equipment in Australia', International Journal of Drug Policy, vol. 34, pp. 65 - 71, http://dx.doi.org/10.1016/j.drugpo.2016.04.005
2016
Fortier E; Alavi M; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ; Bruneau J; Grebely J, 2015, 'The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study', International Journal of Drug Policy, vol. 26, pp. 1094 - 1102, http://dx.doi.org/10.1016/j.drugpo.2015.06.001
2015
Stoové M; Treloar CJ; Maher L; Tyrrell H; Wallace J, 2015, 'Salvaging a prison needle and syringe program trial in australia requires leadership and respect for evidence', Medical Journal of Australia, vol. 203, pp. 319 - 320, http://dx.doi.org/10.5694/mja15.00523
2015
Treloar C; Rance J; Bath N; Everingham H; Micallef M; Day C; Hazelwood S; Grebely J; Dore GJ, 2015, 'Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia', International Journal of Drug Policy, vol. 26, pp. 992 - 998, http://dx.doi.org/10.1016/j.drugpo.2015.01.005
2015
Treloar C; Jackson LC, 2015, 'Commentary on historical trauma, substance use, and Indigenous people: Seven generations from a "big event"', Substance Use and Misuse, vol. 50, pp. 891 - 893, http://dx.doi.org/10.3109/10826084.2015.985567
2015
Treloar C; McCredie L; Lloyd AR, 2015, 'Acquiring hepatitis C in prison: the social organisation of injecting risk', Harm Reduction Journal, vol. 12, http://dx.doi.org/10.1186/s12954-015-0045-2
2015
Alavi M; Micallef M; Fortier E; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ; Grebely J, 2015, 'Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: The ETHOS study', Journal of Viral Hepatitis, vol. 22, pp. 914 - 925, http://dx.doi.org/10.1111/jvh.12415
2015
Rance J; Treloar C, 2015, '"We are people too": Consumer participation and the potential transformation of therapeutic relations within drug treatment', International Journal of Drug Policy, vol. 26, pp. 30 - 36,
2015
Treloar C; Newland J; Maher L, 2015, 'A qualitative study trialling the acceptability of new hepatitis C prevention messages for people who inject drugs: Symbiotic messages, pleasure and conditional interpretations', Harm Reduction Journal, vol. 12, http://dx.doi.org/10.1186/s12954-015-0042-5
2015
Treloar C; Baldry E; Higgs P; Dietze P; Stoove M; Lloyd A, 2015, 'Going Tobacco Free in Australian Prisons - increasing tattoing harm?', International Journal of Prisoner Health, vol. 11, http://dx.doi.org/10.1108/IJPH-04-2015-0011
2015
Alavi M; Micallef M; Fortier E; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ; Grebely J, 2015, 'Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the ETHOS study', Journal of Viral Hepatitis,
2015
Keats J; Micallef M; Grebely J; Hazelwood S; Everingham H; Shrestha N; Jones T; Bath N; Treloar C; Dore GJ; Dunlop A; Haber P; Carolyn D; Gregory D; Tawil V; Krahn M; Loveday S; Thein HH, 2015, 'Assessment and delivery of treatment for hepatitis C virus infection in an opioid substitution treatment clinic with integrated peer-based support in Newcastle, Australia', International Journal of Drug Policy, vol. 26, pp. 999 - 1006, http://dx.doi.org/10.1016/j.drugpo.2015.07.006
2015
Marshall AD; Micallef M; Erratt A; Telenta J; Treloar C; Everingham H; Jones SC; Bath N; How-Chow D; Byrne J; Harvey P; Dunlop A; Jauncey M; Read P; Collie T; Dore GJ; Grebely J, 2015, 'Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife Study', International Journal of Drug Policy, vol. 26, pp. 984 - 991, http://dx.doi.org/10.1016/j.drugpo.2015.07.002
2015
Rance J; Treloar C, 2014, ''Not just Methadone Tracy': Transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings', Addiction, vol. 109, pp. 452 - 459, http://dx.doi.org/10.1111/add.12392
2014
Treloar C; Rance J; Dore GJ; Grebely J, 2014, 'Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: Insights from the ETHOS study', Journal of Viral Hepatitis, vol. 21, pp. 560 - 567,
2014
Treloar C; Rance J; Dore GJ; Grebely J, 2014, 'Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: Insights from the ETHOS study', Journal of Viral Hepatitis, vol. 21, pp. 560 - 567, http://dx.doi.org/10.1111/jvh.12183
2014
Brener L; Rose G; Treloar C; Cama EJ; Whiticker M, 2014, 'Mental health support workers attitudes towards hepatitis c and injecting drug use: Barriers to recovery?', Mental Health and Substance Use: Dual Diagnosis, vol. 7, pp. 217 - 229,
2014
Rance J; Treloar C, 2014, ''Not just Methadone Tracy': Transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings', Addiction, vol. 109, pp. 452 - 459,
2014
Rance J; Treloar C, 2014, ''We are people too': Consumer participation and the potential transformation of therapeutic relations within drug treatment', International Journal of Drug Policy, vol. 26, pp. 30 - 36, http://dx.doi.org/10.1016/j.drugpo.2014.05.002
2014
Treloar C; Rance J, 2014, 'How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting', International Journal of Drug Policy, vol. 25, pp. 865 - 870, http://dx.doi.org/10.1016/j.drugpo.2014.01.011
2014
Treloar C; Rance J; Grebely J; Dore GJ, 2013, 'Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia', Drug and Alcohol Dependence, vol. 133, pp. 529 - 534, http://dx.doi.org/10.1016/j.drugalcdep.2013.07.023
2013
Alavi M; Grebely J; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ, 2013, 'Assessment and treatment of hepatitis c virus infection among people who inject drugs in the opioid substitution setting: ETHOS study', Clinical Infectious Diseases, vol. 57, http://dx.doi.org/10.1093/cid/cit305
2013
Treloar C; Rance J; Backmund M, 2013, 'Understanding barriers to hepatitis c virus care and stigmatization from a social perspective', Clinical Infectious Diseases, vol. 57, http://dx.doi.org/10.1093/cid/cit263
2013
Winter R; Fraser S; Booker N; Treloar C, 2013, 'Authenticity and diversity: Enhancing Australian hepatitis C prevention messages', Contemporary Drug Problems, vol. 40, pp. 505 - 529
2013
Treloar C; valentine K, 2013, 'Examining structural violence in opioid pharmacotherapy treatment in Australia: Sweating the "small stuff" in a liberal paradise', International Journal of Drug Policy, vol. 24, http://dx.doi.org/10.1016/j.drugpo.2013.04.010
2013
Newland J; Treloar C, 2013, 'Peer education for people who inject drugs in New South Wales: Advantages, unanticipated benefits and challenges', Drugs - Education Prevention and Policy, vol. 20, pp. 304 - 311, http://dx.doi.org/10.3109/09687637.2012.761951
2013
Deacon RM; Mooney-Somers J; Treloar C; Maher L, 2013, 'At the intersection of marginalised identities: Lesbian, gay, bisexual and transgender people's experiences of injecting drug use and hepatitis C seroconversion', Health and Social Care in the Community, vol. 21, pp. 402 - 410, http://dx.doi.org/10.1111/hsc.12026
2013
Levy MH; Treloar C, 2012, 'Harm minimisation in Australian prisons—health protection still depends on where you serve your time', Medical Journal of Australia, vol. 197, pp. 382 - 382, http://dx.doi.org/10.5694/mja12.10228
2012
Treloar C; Rance J; Laybutt B; Crawford S, 2012, 'Structural constraints on the training of peer educators in hepatitis C prevention', Health Education Research Theory and Practice, vol. 27, pp. 248 - 257, http://dx.doi.org/10.1093/her/cyr094
2012
Harris MI; Treloar C; Maher L, 2012, 'Staying safe from hepatitis C: Engaging with multiple priorities.', Qualitative Health Research, vol. 22, pp. 31 - 42, http://dx.doi.org/10.1177/1049732311420579
2012
Treloar C; Hull PB; Dore GJ; Grebely J, 2012, 'Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs', Drug and Alcohol Review, vol. 31, pp. 918 - 924, http://dx.doi.org/10.1111/j.1465-3362.2012.00468.x
2012
Deacon RM; Wand H; Stelzer-Braid S; Treloar C; Maher L, 2011, 'Improving surveillance for acute hepatitis C', Communicable Diseases Intelligence Quarterly Report, vol. 35, pp. 16 - 20, http://search.informit.com.au/documentSummary;dn=057496644726691;res=IELHEA
2011
Grebely J; Bryant J; Hull P; Hopwood M; Lavis Y; Dore GJ; Treloar C, 2011, 'Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia', Journal of Viral Hepatitis, vol. 18,
2011
Treloar C; Rance J; Madden A; Liebelt L, 2011, 'Evaluation of consumer participation demonstration projects in five australian drug user treatment facilities: The impact of individual versus organizational stability in determining project progress', Substance Use and Misuse, vol. 46, pp. 969 - 979, http://dx.doi.org/10.3109/10826084.2010.540289
2011
Treloar C; Laybutt B; Carruthers S, 2010, 'Using mindfulness to develop health education strategies for blood borne virus prevention in injecting drug use', Drugs - Education Prevention and Policy, pp. 1465 - 3370, http://dx.doi.org/10.1080/09687630802585377
2010
Treloar C; Rance J; Laybutt B; Crawford S, 2010, 'Working with the ‘hierarchy in the underworld’: insights for communication skills training with peer educators', Contemporary Drug Problems, vol. 37, pp. 639 - 657
2010
Dore G; Grebely J; Gillman A; Thein R; Day C; Ryan L; Treloar C; Haber P, 2010, 'PRESENTER 1: OVERVIEW OF TREATMENT OF HEPATITIS C (HCV) IN THE OPIATE PHARMACOTHERAPY SETTING AND THE ENHANCING TREATMENT OF HEPATITIS C IN THE OPIATE SUBSTITUTION SETTING (ETHOS) PARTNERSHIP INITIATIVE', DRUG AND ALCOHOL REVIEW, vol. 29, pp. 21 - 21, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284895600048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2010
Treloar C; Newland J; Harris M; Deacon R; Maher L, 2010, 'A diagnosis of hepatitis C: Insights from a study on patient’s experiences.', Australian Family Physician, vol. 39, pp. 589 - 592, http://www.racgp.org.au/afp/201008/201008treloar.pdf
2010
Treloar C; Laybutt B; Carruthers S, 2010, 'Using mindfulness to develop health education strategies for blood borne virus prevention in injecting drug use', Drugs: Education, Prevention and Policy, vol. 17, pp. 431 - 442, http://dx.doi.org/10.3109/09687630802585377
2010
Treloar C; Byron P; Mccann P; Maher L, 2010, 'Fitness for duty: social, organisational and structural influences on the design and conduct of candidate hepatitis C vaccine trials involving people who inject drugs', Vaccine, vol. 28, pp. 5228 - 5236, http://dx.doi.org/10.1016/j.vaccine.2010.05.064
2010
Garvey G; Rolfe I; Pearson S; Treloar C, 2009, 'Indigenous Australian medical students' perceptions of their medical school training', Medical Education, vol. 43, pp. 1047 - 1055, http://dx.doi.org/10.1111/j.1365-2923.2009.03519.x
2009
Treloar C; Holt M, 2008, 'Drug treatment clients` readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings', Australian Health Review, vol. 32, pp. 570 - 576, http://dx.doi.org/10.1071/AH080570
2008
Treloar C; Holt M, 2008, 'Complex vulnerabilities as barriers to treatment for illicit drug users with high prevalence mental health comorbidities', Mental Health and Substance Use: Dual Diagnosis, vol. 1, pp. 84 - 95
2008
Holt M; Treloar C, 2008, 'Managing mental health problems in everyday life: drug treatment clients` self-care strategies', International Journal of Mental Health and Addiction, vol. 6, pp. 421 - 431, http://dx.doi.org/10.1007/s11469-007-9114-4
2008
Treloar C; Laybutt B; Jauncey ME; Van Beek IA; Lodge M; Malpas G; Carruthers S, 2008, 'Broadening discussions of `safe` in hepatitis C prevention: A close-up of swabbing in an analysis of video recordings of injecting practice', International Journal of Drug Policy, vol. 19, pp. 59 - 65, http://dx.doi.org/10.1016/j.drugpo.2007.01.005
2008
Holt M; Treloar C, 2008, 'Pleasure and drugs', International Journal of Drug Policy, vol. 19, pp. 349 - 352, http://dx.doi.org/10.1016/j.drugpo.2007.12.007
2008
Holt M; Treloar C, 2008, 'Understanding comorbidity? Australian service-user and provider perspectives on drug treatment and mental-health literacy', Drugs - Education Prevention and Policy, vol. 15, pp. 518 - 531, http://dx.doi.org/10.1080/09687630701690674
2008
Sutton R; Treloar C, 2007, 'Chronic illness experiences, clinical markers and living with hepatitis C', Journal of Health Psychology, vol. 12, pp. 330 - 340, http://dx.doi.org/10.1177/1359105307074278
2007
Digiusto EA; Treloar C, 2007, 'Equity of access to treatment, and barriers to treatment for illicit drug use in Australia', Addiction, vol. 102, pp. 958 - 969, http://dx.doi.org/10.1111/j.1360-0443.2007.01842.x
2007
Levy MH; Treloar C; Booker N; McDonald R, 2007, 'Prisons, hepatitis c and harm minimisation', Medical Journal of Australia, vol. 186, pp. 647 - 649
2007
Fry C; Treloar C; Maher L, 2007, 'Applied communitarian ethics for harm reduction: Promoting a dialogue within the field.', Drug and Alcohol Review, vol. 26, pp. 553 - 555, http://dx.doi.org/10.1080/09595230701499183
2007
Körner H; Treloar C, 2006, 'Representations of people with HIV and hepatitis C in editorials of medical journals: Discourses and interdiscursive relations', Communication and Medicine, vol. 3, pp. 15 - 25, http://dx.doi.org/10.1515/CAM.2006.003
2006
Treloar C; Holt M, 2006, 'Deficit models and divergent philosophies: Service providers` perspectives on barriers and incentives to drug treatment', Drugs - Education Prevention and Policy, vol. 13, pp. 367 - 382, http://dx.doi.org/10.1080/09687630600761444
2006
Cao W; Treloar C, 2006, 'Comparison of needle and syringe programme attendees and non-attendees from a high drug-using area in Sydney, New South Wales', Drug and Alcohol Review, vol. 25, pp. 439 - 444, http://dx.doi.org/10.1080/09595230600891282
2006
Treloar C; Cao W, 2005, 'Barriers to use of needle and syringe programs in a high drug use area of Sydney, New South Wales', International Journal of Drug Policy, vol. 16, pp. 308 - 315, http://dx.doi.org/10.1016/j.drugpo.2005.06.005
2005
Duke JM; Treloar C; Byles JE, 2005, 'Evaluation of a revised instrument to assess the needs of men diagnosed with prostate cancer', Supportive Care in Cancer, vol. 13, pp. 895 - 903, http://dx.doi.org/10.1007/s00520-005-0808-5
2005
Byles JE; D'Este C; Parkinson L; O'Connell R; Treloar C, 2005, 'Single index of multimorbidity did not predict multiple outcomes', Journal of Clinical Epidemiology, vol. 58, pp. 997 - 1005, http://dx.doi.org/10.1016/j.jclinepi.2005.02.025
2005
Treloar C, 2005, ''You sort of switch off': Exploring mindlessness in injecting drug users' accounts of blood', Journal of Health Psychology, vol. 10, pp. 137 - 145, http://dx.doi.org/10.1177/1359105305048560
2005
Moxey AJ; O Connell DL; Treloar C; Han P; Henry D, 2005, 'Blood transfusion and autologous donation: a survey of post-surgicalpatients, interest group members and the public', Transfusion Medicine, vol. 15, pp. 19 - 32, http://dx.doi.org/10.1111/j.1365-3148.2005.00544.x
2005
Doab AE; Treloar C; Dore GJ, 2005, 'Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia', Clinical Infectious Diseases, vol. 40, pp. S313 - S320, http://dx.doi.org/10.1086/427446
2005
Fry C; Treloar C; Maher L, 2005, 'Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics', Drug and Alcohol Review, vol. 24, pp. 449 - 459, http://dx.doi.org/10.1080/09595230500263905
2005
Treloar C; Korner H, 2005, 'NSPs and the media: A case study of balanced and accurate reporting?', Australian and New Zealand Journal of Public Health, vol. 29, pp. 489 - 490, http://dx.doi.org/10.1111/j.1467-842X.2005.tb00234.x
2005
Treloar C; Elek C; Wilkins R, 2005, 'Incorporating the message: Research dissemination with the injecting drug use field', International Journal of Health Promotion and Education, vol. 43, pp. 75 - 80, http://dx.doi.org/10.1080/14635240.2005.10708044
2005
Korner H; Treloar C, 2004, 'Needle and syringe programmes in the local media: `needle anger` versus `effective education in the community`', International Journal of Drug Policy, vol. 15, pp. 46 - 55, http://dx.doi.org/10.1016/S0955-3959(03)00089-6
2004
Fraser S; Treloar C, 2004, 'Letter to the editor', Journal of Substance Use, vol. 9, pp. 252, http://dx.doi.org/10.1080/14659890410001711742
2004
Robertson J; Treloar CJ; Sprogis A; Henry DA, 2003, 'The influence of specialists on prescribing by GPs. A qualitative study.', Australian family physician, vol. 32, pp. 573 - 576
2003
Duke JM; Treloar CJ; Byles JE, 2003, 'Evaluation of an instrument to assess the needs of men diagnosed with prostate carcinoma: An assessment of the validity and reliability of a self-administered questionnaire developed to measure the needs experienced by men diagnosed with prostate carcinoma', Cancer, vol. 97, pp. 993 - 1001, http://dx.doi.org/10.1002/cncr.11156
2003
Tolhurst H; Talbot J; Baker L; Bell P; Murray G; Sutton A; Dean S; Treloar C; Harris G, 2003, 'Rural general practitioner apprehension about work related violence in Australia', Australian Journal of Rural Health, vol. 11, pp. 237 - 241, http://dx.doi.org/10.1111/j.1440-1584.2003.00526.x
2003
Treloar CJ; Hewitson PJ; Henderson KM; Harris G; Henry D; McGrath KM, 2001, 'Factors influencing the uptake of technologies to minimize perioperative allogeneic blood transfusion: An interview study of national and institutional stakeholders', Internal Medicine Journal, vol. 31, pp. 230 - 236, http://dx.doi.org/10.1046/j.1445-5994.2001.00047.x
2001
Treloar C; Champness S; Simpson PL; Higginbotham N, 2000, 'Critical appraisal checklist for qualitative research studies', Indian Journal of Pediatrics, vol. 67, pp. 347 - 351, http://dx.doi.org/10.1007/BF02820685
2000
Mukti AG; Treloar C; Suprawimbarti ; Asdie AH; D'Este K; Higginbotham N; Heller R, 2000, 'A universal precautions education intervention for health workers in Sardjito and PKU Hospital Indonesia', Southeast Asian Journal of Tropical Medicine and Public Health, vol. 31, pp. 405 - 411
2000
Nair BR; Treloar CJ; Harris G, 2000, 'Do we need a new word for patients?', Australian and New Zealand Journal of Medicine, vol. 30, pp. 716 - 717, http://dx.doi.org/10.1111/j.1445-5994.2000.tb04367.x
2000
Evans K; Mayer J; Treloar C, 2000, 'Who cares? A focus group study on follow up care after discharge from hospital.', Australian family physician, vol. 29, pp. 384 - 388
2000
Treloar C; McCall N; Rolfe I; Pearson SA; Garvey G; Heathcote A, 2000, 'Factors affecting progress of Australian and international students in a problem-based learning medical course', Medical Education, vol. 34, pp. 708 - 715, http://dx.doi.org/10.1046/j.1365-2923.2000.00625.x
2000
Boots RJ; Treloar C, 2000, 'Prediction of intern attendance at a seminar-based training programme: A behavioural intention model', Medical Education, vol. 34, pp. 512 - 518, http://dx.doi.org/10.1046/j.1365-2923.2000.00567.x
2000
Henry DA; Henderson KM; Fryer JL; Treloar CJ; McGrath KM; Deveridge SF, 2000, 'Use of interventions to minimise perioperative allogeneic blood transfusion in Australia: A survey by the International Study of Perioperative Transfusion (ISPOT) study group', Medical Journal of Australia, vol. 172, pp. 365 - 369
2000
Treloar C; Porteous J; Hassan F; Kasniyah N; Lakshmanudu M; Sama M; Sja'Bani M; Heller RF, 1999, 'The cross cultural context of obesity: An INCLEN multicentre collaborative study', Health and Place, vol. 5, pp. 279 - 286, http://dx.doi.org/10.1016/S1353-8292(99)00018-0
1999
Treloar CJ, 1998, 'Evaluation of a national and international distance education programme in clinical epidemiology', Medical Education, vol. 32, pp. 70 - 75, http://dx.doi.org/10.1046/j.1365-2923.1998.00168.x
1998
Treloar C, 1997, 'Developing a multilevel understanding of heart disease: An interview study of MONICA participants in an Australian center', Qualitative Health Research, vol. 7, pp. 468 - 486, http://dx.doi.org/10.1177/104973239700700403
1997
Treloar CJ, 1996, 'An 'academic detailing' intervention to decrease exposure to HIV infection among health-care workers', Journal of Health Psychology, vol. 1, pp. 455 - 468, http://dx.doi.org/10.1177/135910539600100404
1996
Treloar CJ; Higginbotham N; Malcolm JA; Sutherland DC; Berenger S, 1995, 'The personal experience of Australian health-care workers accidentally exposed to risk of HIV infection [7]', AIDS, vol. 9, pp. 1385 - 1386, http://dx.doi.org/10.1097/00002030-199512000-00018
1995
Treloar CJ; Malcolm JA; Sutherland DC; Berenger S; Higginbotham N, 1994, 'Hospital administrators' tolerance of staff needlestick injuries', Infection Control & Hospital Epidemiology, vol. 15, pp. 307 - 310, http://dx.doi.org/10.1086/646917
1994
Other
add
Treloar C, 2013, Reflections on the practice of treatment for drug dependence, Hektoen Institute of Medicine
2013
Valentine K; Treloar C, 2013, Response to Chandler et al., Substance, structure and stigma: Parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods, http://dx.doi.org/10.1016/j.drugpo.2013.07.006
2013
Neale J; Hunt G; Lankenau S; Maycock P; Miller P; Sheridan J; Small W; Treloar C, 2013, Addiction journal is committed to publishing qualitative research, Wiley, http://dx.doi.org/10.1111/add.12051
2013
Treloar C, 2010, The proof is in the toothpaste: Police ordered exclusion as a result of research participation, http://dx.doi.org/10.1111/j.1753-6405.2010.00605.x
2010
Reports
add
Adam P; de Wit J; Ketsuwan I; Treloar C, 2019, Sexual health-related knowledge, attitudes and practices of young people in Australia: Results from the 2018 Debrief Survey, Centre for Social Research in Health, UNSW Sydney, Sydney,
2019
Hopwood M; Treloar C, 2019, Hepatitis B-related stigma among Chinese Australians living in Sydney (Summary report), Centre for Social Research in Health, UNSW Sydney, Sydney,
2019
Bell S; Treloar C, 2014, Evidence-based practice in HIV, STI and Viral hepatitis health promotion and Aboriginal community engagement, CSRH, UNSW Sydney
2014
Adam PC; de Wit JB F; Treloar C; Shepherd B; Duck T; Byron P; Bourne C; Murray C; Welsby D; Holden J, 2014, Towards an online periodic survey of sexual health among young people in Australia, Centre for Social Research in Health, UNSW Australia., Sydney, Monograph 8/2014,
2014
de Wit J; Mao L; Adam P; Treloar C, 2014, HIV/AIDS, hepatitis and sexually transmissible infections in Australia: Annual Report of trends in behaviour 2014, Sydney: Centre for Social Research in Health, UNSW, Australia, https://csrh.arts.unsw.edu.au/media/CSRHFile/Annual_Report_of_Trends_in_Behaviour_2014.pdf
2014
de Wit J; Mao L; Holt M; Treloar C, 2013, HIV/AIDS, hepatitis and sexually transmissible infections in Australia: Annual Report of trends in behaviour 2013, Centre for Social Research in Health, UNSW Australia, Sydney, https://csrh.arts.unsw.edu.au/media/CSRHFile/1_ARTB_2013_report.pdf
2013
Rance J; Treloar C, 2012, Integrating Treatment: Key findings from a qualitative evaluation of the Enhancing Treatment of Hepatitis C in Opiate Substitution Settings, National Centre in HIV Social Research, The University of New South Wales, Sydney, Integrating treatment: key findings from a qualitative evaluation of the Enhancing Treatment of Hepatitis C in Opiate Substitution Settings (ETHOS) study, http://nchsr.arts.unsw.edu.au/media/File/Integrating_treatment.pdf
2012
Wilson H; Hopwood MN; Hull PB; Lavis YM; Newland J; Bryant J; Treloar C, 2010, Treatment decisions: What makes people decide to have treatment for hepatitis C?, National Centre in HIV Social Research, The University of New South Wales, Sydney, Treatment decisions: What makes people decide to have treatment for hepatitis C?, http://nchsr.arts.unsw.edu.au/media/File/Treatment_decisions.pdf
2010
de Wit J; Treloar C; Wilson H, 2009, HIV/AIDS, hepatitis and sexually transmissible infections in Australia: Annual report of trends in behaviour 2009
2009
Holt M; Treloar C; Schultz L; Schultz M; Bath N, 2007, Barriers and incentives to treatment for illicit drug users with mental health comorbidities and complex vulnerabilities, Australian Government Department of Health and Ageing, Canberra, Barriers and incentives to treatment for illicit drug users with mental health comorbidities and complex vulnerabilities (National Drug Strategy Monograph Series no. 61), http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/publishing.nsf/Content/mono61
2007
Fraser S; valentine K; Treloar C; McMillan KE, 2007, Methadone maintenance treatment in New South Wales and Victoria: takeaways, diversion and other key issues, National Centre in HIV Social Research, The University of New South Wales, Sydney, http://nchsr.arts.unsw.edu.au/pdf%20reports/Methadone2007.pdf
2007
Fraser S; Valentine K; Treloar C; McMillan KE, 2007, Methadone maintenance treatment in New South Wales and Victoria: Takeaways, diversion and other key issues, National Centre in HIV Social Research, Sydney, Methadone maintenance treatment in New South Wales and Victoria: Takeaways, diversion and other key issues
2007
Rawstorne PR; Treloar C; Richters J, 2005, Annual report of behaviour 2005: HIV/AIDS, hepatitis & sexually transmissible infections in Australia, National Centre in HIV Social Research, Sydney, Original
2005
Treloar C; Booth G; Cao W; Trask L; Lowth A; Weatherall A; Dixon J; Denoe M; MacDonald MA; Laybutt B, 2004, Access to harm reduction services and `hidden` injectors: Access issues, knowledge, and risk practice among people who infrequently use primary NSPs in south-east Sydney, summary of findings, National Centre in HIV Social Research, Sydney, Original
2004
Van De Ven PG; Rawstorne PR; Treloar C; Richters J, 2004, Annual report of behaviour 2004: HIV/AIDS, hepatitis & sexually transmissible infections in Australia, National Centre in HIV Social Research, Sydney, Original
2004
Treloar C; Crawford J; Kippax SC; Howard J; Van Beek IA; Copeland J; Weatherall A; Madden A, 2003, Risk for hepatitis C: Transition and initiation to injecting drug use among youth in a range of injecting drug user networks, National Centre in HIV Social Research, Sydney, Original
2003